In colorectal cancer, it has been found that ctDNA is more sensitive than the detection of serum protein biomarkers such as carcinoembryonic antigen (CEA), showing tighter changes in response to tumor resection and a greater predictive capacity for recurrence. This evidence concerns the gene CEACAM5 and neoplasm.